SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-15-067514
Filing Date
2015-09-28
Accepted
2015-09-28 06:06:34
Documents
13
Period of Report
2015-09-27
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-20183_18k.htm 8-K 21281
2 EX-99.1 a15-20183_1ex99d1.htm EX-99.1 49287
3 EX-99.2 a15-20183_1ex99d2.htm EX-99.2 141905
4 EX-99.3 a15-20183_1ex99d3.htm EX-99.3 70937
5 GRAPHIC g201831mqi001.gif GRAPHIC 6497
6 GRAPHIC g201831moi001.gif GRAPHIC 3321
7 GRAPHIC g201831moi002.gif GRAPHIC 55196
8 GRAPHIC g201831moi003.gif GRAPHIC 2538
9 GRAPHIC g201831mmi001.gif GRAPHIC 2282
10 GRAPHIC g201831mmi002.gif GRAPHIC 45501
11 GRAPHIC g201831mmi003.gif GRAPHIC 46392
12 GRAPHIC g201831mmi004.gif GRAPHIC 42800
13 GRAPHIC g201831mmi005.gif GRAPHIC 2538
  Complete submission text file 0001104659-15-067514.txt   570927
Mailing Address 951 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 951 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6502389600
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 151126136
SIC: 2834 Pharmaceutical Preparations